Article
Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
The Journal of antimicrobial chemotherapy - 1 Feb 2010
Gudiol Carlota, Calatayud Laura, Garcia-Vidal Carolina, Lora-Tamayo Jaime, Cisnal María, Duarte Rafael, Arnan Montserrat, Marin Mar, Carratalà Jordi, Gudiol Francesc
Abstract excerpt
OBJECTIVES: To assess the clinical features, risk factors, molecular epidemiology and outcome of extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) bacteraemia in hospitalized cancer patients. METHODS: Episodes of ESBL-EC bacteraemia were compared with a susceptible control gro...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.